I n our small series, n e i t h e r the mode of d e l i v e r y , nor breast-feeding,
were r e l a t e d t o v e r t i c a l l y t r a n s m i t t e d HIV i n f e c t i o n .
KAWASAKI SYNDROME IN BERNE, SWITZERLAND, 1977 -1986 ; REVIEW OF 26 PATIENTS. Urs B Schaad, K a r i n Odermatt JW Weber and FP Stocker. Department o f p e d i a t r i i s ( I n s e l s p i t a l ) , U n i v e r l s t y o f Berne, CH-3010 Berne, Switzerland. The purposes o f t h i s r e t r o s p e c t i v e study o f the 26 p a t i e n t s (17 male (67%), 9 female (35%); mean age SD = 2.8 2 years) t r e a t e d f o r Kawasaki syndrome a t our c e n t r e since 1977 were t o describe t h e i r c l i n i c a l and l a b o r a t o r y presentation, and t o evaluate h i g h -r i s k f a c t o r s f o r the development o f coronary a r t e r i a l complications and e f f e c t s o f d i f f e r e n t therapies i n preventing the coronary involvement.
The diagnostic c r i t i e r i a were met by 100% f o r fever and rash, by 96% f o r d i g i t a l desquamation, by 92% f o r b i l a t e r a l c o n j u n c t i v a l i n j e c t i o n and mucous membrane changes, by 81% f o r c e r v i c a l lymphadenopathy, and by 54% f o r peripheral edemalerythema. Treatment included a s p i r i n , i n t h e beginning a l s o a n t i b i o t i c s , and since 1986 highdose intravenous imnune g l o b u l i n s (IVIG). Regular r o u t i n e electrocardiogram and echocardiogram c o n t r o l s recorded 9 cardiovascular complications: 6x c a r d i t i s (23%) and 3x coronary a r t e r y aneurysm (12%). The 3 p a t i e n t s w i t h coronary aneurysm were a l l males, and compared t o the others b o t h younger (22 us. 33 mths) and f e b r i l e over a longer p e r i o d o f time (22 vs 12 dys); elevated acute-phase reactants such as ESR, leukocyte and p l a t e l e t counts were s i m i l a r i n both groups and d i d n o t a f f e c t prognosis.
Since the therapeutic use o f IVIG no more cardiac complications were detected. A l l p a t i e n t s are c l i n i c a l l y cured. The f i n d i n g s o f c a r d i t i s i n 6 and o f coronary aneurysm i n 2 p a t i e n t s completely resolved; one p a t i e n t w i t h regressive coronary aneurysm shows myopathic cardiomegaly a f t e r 2 y r s .
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GAMMAGLOBULINS J .C. Borderon, Y. Lebranchu Centre de P e d i a t r i e Gatien de C l o c h e v i l l e 49. Bd Beranger 37000 TOURS (France) Twenty e i g h t i n f a n t s and c h i l d r e n (3-63 months) w i t h Kawasaki disease received intravenous imnunoglobul i ns (IVIG) i n a m u l t i c e n t r i c study: Veinoglobulin (Merieux, France) i n 24 cases o r Sandoglobulin (Sandoz, Switzerland) i n 4 cases. The t o t a l amount administered was i n the range 1-2.5g/Kg and v a r i e d from 1 t o 5 d a i l y i n f u s i o n s . I n 16 cases the p a t i e n t s received 0.4 mg/Kg/day during 5 consecutive days. A l l o f them were given o r a l l y a c e t y l s a l i c y l i c a c i d 30 mg/Kg/day during a 2 month period.
A dramatic improvement i n the p a t i e n t s ' general c o n d i t i o n was observed, w i t h r e s o l u t i o n o f f e v e r w i t h i n 48 hours. Hyperfibrinemia and hyperleucocytosis returned t o normal i n one week and incresed p l a t e l e t s w i t h i n 2-3 weeks.
An important f e a t u r e was t h a t follow-up echocardiograms over more than one year have demonstrated no coronary a r t e r y abnormalities. I n November 1984 Furusho e t a1 published t h e i r r e s u l t s suggesting t h a t IV IGG prevents coronary a r t e r y aneurysm formation i n Kawasaki Disease.
These r e s u l t s were confirmed i n an open c o n t r o l l e d m u l t i c e n t e r study by Newburger e t a1 i n 1986.
I n F i n l a n d new cases o f KD have been r e g i s t e r e d since 1981.
To determine the value o f IV IGG i n F i n n i s h KD p a t i e n t s the records o f p a t i e n t s r e g i s t e r e d i n 1985-87 were reviewed.
Seventy-one p a t i e n t s were r e g i s t e r e d . Data on b o t h treatment and f i n d i n g s o f coronary echocardiography were a v a i l a b l e on 63 p a t i e n t s .
Coronary aneurysms were detected i n 3/44 p a t i e n t s t r e a t e d w i t h a s p i r i n + IV IGG and 3/19 p a t i e n t s t r e a t e d w i t h a s p i r i n only. Two o f the untreated c h i l d r e n w i t h aneurysms f u l f i l l e d o n l y 4 o f t h e 6 c r i t e r i a o f KD. These data are i n accord w i t h the suggested b e n e f i t o f IV IGG i n preventing aneurysm formation i n KO. When t r e a t i n g Kawasaki p a t i e n t s w i t h IV IGG we are f a c i n g the f o l l o w i n g problems: -p a t i e n t s w i t h diseases o t h e r than KD w i l l be treated; -KD p a t i e n t s n o t f u l f i l l i n g the c r i t e r i a w i l l n o t be t r e a t e d o r t h e i r treatment w i l l be delayed;
-an occasional p a t i e n t w i t h IgA d e f i c i e n c y w i l l be treated; -the f i n a l diagnosis may be obscured as the treatment m o d i f i e s the c l i n i c a l p i c t u r e and i n v a l i d a t e s the r e s u l t s o f b a c t e r i a l and v i r a l serology.
C-REACTIVE PROTEIN IN KAWASAKI DISEASE
J . Boulloche * E. M a l l e t * F. P o l l e t * * e t a1 .*** 9 t o l l a b o r a t i v : study ~~~~' E V R E U X ( * * ) , LISEUX (***) ROUEN (*) C h i l d r e n ' s H o s p i t a l s -France.
C-r e a c t i v e p r o t e i n (CRP) l e v e l s were i n v e s t i g a t e d i n 8 cases o f Kawasaki disease (KO) a l l t r e a t e d w i t h h i g h doses o f intravenous gamnaglobulin (400 mg/kg) f o r 3 days).
Medium i n i t i a l value o f CRP was 190 mg/100 ml (range 129-284).
The delay between the onset o f the disease and treatment was 12.5 days (5-24).
I n a l l cases CRP normalized d r a m a t i c a l l y w i t h a mean delay o f 3.5 days (range 0-7dys) a f t e r t h e end o f treatment.
This b i o l o g i c parameter normalized b e f o r e o t h e r inflamnatory t e s t s , such as e r y t h r o c y t e sedimentation r a t e , p l a t e l e t count, f i b r i n o g e n and IgE.
Both apyrexia occured and s k i n l e s i o n s e v o l u t i o n stopped.
One p a t i e n t w i t h coronary a r t e r y involvement was t r e a t e d a f t e r a delay o f 24 days when cardiac l e s i o n s were already present.
CRP value was normal 24 hours a f t e r the onset o f treatment and coronary l e s The f i r s t LGB p a t i e n t s i n Hungary were diagnosed i n 1984, and a few more i n 1985.
But o n l y f o l l o w i n g the i n t r o d u c t i o n of s e r o l o g i c a l t e s t s ( i n d i r e c t immunofluorescence) i n 1986 t h a t i n t e r e s t i n the i l l n e s s was aroused.
During the l a s t two vears more than 2000 sera and CSF samples from 1400 p a t i e n t s h v e been t e s t e d f o r B o r r e l i a b u r g d o r f e r i antibody. 92 o f 1400 p a t i e n t s suffered from p e r i p h e r i a l f a c i a l palsy. 35/92 were found t o be s e r o l o q i c a l l v p o s i t i v e .
19 o f them were seen during the sumner and f a l l of-1987.
I n t h i s year t w i c e as many D e l l ' s palsy p a t i e n t s were seen i n our h o s p i t a l s than i n previous years.
Of the 35 c l i n i c a l l y and s e r o l o g i c a l l y proven cases: 14 showed ECM; 10 had other neurological m a n i f e s t a t i o n s (Bannwarth's syndrome); 1 had frank a r t h r i t i s ; 1 had c a r d i t i s . 18/33 s e r o p o s i t i v e B e l l ' s palsy p a t i e n t s were c h i l d r e n . The c l i n i c a l p i c t u r e , epidemiology, serology and CSF f i n d i n g s o f these cases w i l l be discussed.
Almost a l l of the s e r o p o s i t i v e p a t i e n t s became f r e e o f symptoms.
The l o n g e s t p e r i o d o f recovery was 100 days.
Residual symptom was found o n l y i n those p a t i e n t s t h a t remained seronegative d u r i n g a minimum o f 45 days s e r o l o g i c a l follow-up p e r i o d o r d i d n o t receive adequate parenteral a n t i b i o t i c therapy.
H a l f o f the s e r o p o s i t i v e p a t i e n t s had lymphocytic meningitis. Only one seronegative case had p l e o c y t o s i s i n t h e CSF.
